| Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial M Azizi, RE Schmieder, F Mahfoud, MA Weber, J Daemen, J Davies, ... The Lancet 391 (10137), 2335-2345, 2018 | 675 | 2018 |
| Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised … M Azizi, M Sapoval, P Gosse, M Monge, G Bobrie, P Delsart, M Midulla, ... The Lancet 385 (9981), 1957-1965, 2015 | 522 | 2015 |
| Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial M Azizi, K Sanghvi, M Saxena, P Gosse, JP Reilly, T Levy, LC Rump, ... The Lancet 397 (10293), 2476-2486, 2021 | 232 | 2021 |
| A genetic mouse model recapitulates immune checkpoint inhibitor–associated myocarditis and supports a mechanism-based therapeutic intervention SC Wei, WC Meijers, ML Axelrod, NAAS Anang, EM Screever, ... Cancer discovery 11 (3), 614-625, 2021 | 176 | 2021 |
| Adherence to antihypertensive treatment and the blood pressure–lowering effects of renal denervation in the renal denervation for hypertension (DENERHTN) trial M Azizi, H Pereira, I Hamdidouche, P Gosse, M Monge, G Bobrie, ... Circulation 134 (12), 847-857, 2016 | 160 | 2016 |
| Renal Denervation for Hypertension (DENERHTN) investigators. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant … M Azizi, M Sapoval, P Gosse, M Monge, G Bobrie, P Delsart, M Midulla, ... Lancet 385 (9981), 1957-1965, 2015 | 152 | 2015 |
| Clinical and genetic spectrum of Bartter syndrome type 3 E Seys, O Andrini, M Keck, L Mansour-Hendili, PY Courand, C Simian, ... Journal of the American Society of Nephrology 28 (8), 2540-2552, 2017 | 123 | 2017 |
| Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial MP Schlaich, M Bellet, MA Weber, P Danaietash, GL Bakris, JM Flack, ... The Lancet 400 (10367), 1927-1937, 2022 | 83 | 2022 |
| Atlas of tissue renin-angiotensin-aldosterone system in human: a transcriptomic meta-analysis A Nehme, C Cerutti, N Dhaouadi, MP Gustin, PY Courand, K Zibara, ... Scientific reports 5 (1), 10035, 2015 | 72 | 2015 |
| Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertension PY Courand, GP Jomir, C Khouatra, C Scheiber, S Turquier, JC Glérant, ... European Respiratory Journal 45 (1), 139-149, 2015 | 69 | 2015 |
| Worrying decrease in hospital admissions for myocardial infarction during the COVID-19 pandemic P Lantelme, SC Targe, P Metral, T Bochaton, S Ranc, MLB Zaimi, ... Archives of cardiovascular diseases 113 (6-7), 443-447, 2020 | 60 | 2020 |
| Spontaneous coronary artery dissection in a patient with COVID-19 PY Courand, B Harbaoui, M Bonnet, P Lantelme Cardiovascular Interventions 13 (12), e107-e108, 2020 | 58 | 2020 |
| Twenty-four-hour blood pressure monitoring to predict and assess impact of renal denervation: the DENERHTN study (renal denervation for hypertension) P Gosse, A Cremer, H Pereira, G Bobrie, G Chatellier, B Chamontin, ... Hypertension 69 (3), 494-500, 2017 | 55 | 2017 |
| Reproducibility in echocardiographic assessment of diastolic function in a population based study (the STANISLAS Cohort study) Z Frikha, N Girerd, O Huttin, PY Courand, E Bozec, A Olivier, Z Lamiral, ... PloS one 10 (4), e0122336, 2015 | 48 | 2015 |
| Resistance to insulin in patients with Gitelman syndrome and a subtle intermediate phenotype in heterozygous carriers: a cross-sectional study A Blanchard, M Vallet, L Dubourg, M Hureaux, J Allard, JP Haymann, ... Journal of the American Society of Nephrology 30 (8), 1534-1545, 2019 | 47 | 2019 |
| Development of a risk score based on aortic calcification to predict 1-year mortality after transcatheter aortic valve replacement P Lantelme, H Eltchaninoff, M Rabilloud, G Souteyrand, M Dupré, ... JACC: Cardiovascular Imaging 12 (1), 123-132, 2019 | 42 | 2019 |
| Churg–Strauss syndrome presenting with acute myocarditis and cardiogenic shock PY Courand, P Croisille, C Khouatra, V Cottin, G Kirkorian, E Bonnefoy Heart, Lung and Circulation 21 (3), 178-181, 2012 | 38 | 2012 |
| Resistant hypertension and atherosclerotic renal artery stenosis: effects of angioplasty on ambulatory blood pressure. A retrospective uncontrolled single-center study PY Courand, M Dinic, A Lorthioir, G Bobrie, C Grataloup, N Denarie, ... Hypertension 74 (6), 1516-1523, 2019 | 37 | 2019 |
| Significance, prognostic value and management of heart rate in hypertension PY Courand, P Lantelme Archives of cardiovascular diseases 107 (1), 48-57, 2014 | 37 | 2014 |
| A genetic mouse model recapitulates immune checkpoint inhibitor-associated myocarditis and supports a mechanism-based therapeutic intervention. Cancer Discov. 2021; 11: 614–625 … SC Wei, WC Meijers, ML Axelrod, NAS Anang, EM Screever, EC Wescott, ... DOI: https://doi. org/10.1158/2159-8290. CD-20-0856, 614-625, 0 | 37 | |
